Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- No phaseTaking peopleMesogastrium Metastasis in Colon Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Jichao Qin
See details and how to joinNCT04980287 - 3. fázisTaking peopleNeoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 210
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06850090 - 2. fázisTaking peopleLow-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Sun Yat-sen University
See details and how to joinNCT07448142 - No phaseTaking peopleConcordance Between Large Language Model and Multidisciplinary Team Recommendations in Rectal Cancer
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 180
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT07595107 - 2. fázisNot yet taking people in KínaA Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07814417 · EU 2026-526138-23-00 - 2. fázisNot yet taking people in KínaIntestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in Solid Tumors With Liver Metastases
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 120
- Run by
- Bing Xia
See details and how to joinNCT07875465 - 1. fázisNot yet taking people in KínaPhase 1 Study of NW-301V TCR-T Cells in Advanced Solid Tumors With KRAS G12V Mutation
- Where
- Beijing, Hangzhou
- Életkor
- 18 év to 75 év
- People
- 66
- Run by
- Neowise Biotechnology
See details and how to joinNCT07875920 - 2. fázisTaking peopleA Study of YL202 in Patients With Advanced Solid Tumors
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 100
- Run by
- MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07202364 - No phaseNot yet taking people in KínaA Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With Cetuximab and mFOLFIRI Regimen as First-Line Treatment for Recurrent or Metastatic Colorectal Cancer
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 55
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07874438 - 1/2. fázisTaking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Beijing, Jinan, Shanghai, Suzhou
- Életkor
- 18 év and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - 2. fázisTaking peopleDelayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Shandong Cancer Hospital and Institute
See details and how to joinNCT06778382 - 3. fázisTaking peopleFAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 198
- Run by
- Fudan University
See details and how to joinNCT07815834 - 3. fázisTaking peopleSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Where
- Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Meizhou, Mianyang, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Wuhan, Xiamen
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Pfizer
See details and how to joinNCT07222800 · EU 2025-523521-18-00 - 2. fázisNot yet taking people in KínaA Prospective, Biomarker-Stratified Phase 2 Study: β-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 144
- Run by
- Tao Zhang
See details and how to joinNCT07847229 - 3. fázisTaking peopleComparing Efficacy and Safety of Enlituo® Versus Erbitux® Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status.
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 608
- Run by
- Taizhou Mabtech Pharmaceutical Co.,Ltd
See details and how to joinNCT07595276 - No phaseNot yet taking people in KínaA Clinical Study on the Synergistic Effects of Zhen-Qi-Jie-Du Granules in Palliative Care for Advanced Colorectal Cancer
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 1540
- Run by
- Jiangsu Famous Medical Technology Co., Ltd.
See details and how to joinNCT07854405 - 2. fázisTaking peoplePULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06788171 - Korai 1. fázisTaking peopleSafety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 15
- Run by
- Base Therapeutics (Shanghai) Co., Ltd.
See details and how to joinNCT07166263 - No phaseTaking peopleA Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)
- Where
- Guangdong
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Jie Yuan,MD
See details and how to joinNCT07850882 - No phaseTaking peopleTamsulosin for Early Catheter Removal After Rectal Cancer Surgery
- Where
- Changchun, Harbin
- People
- 1545
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07346586 - 2/3. fázisTaking peopleNode-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 430
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06958432 - 1/2. fázisNot yet taking people in KínaTQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread
- Where
- Beijing, Changsha, Foshan, Harbin, Lanzhou, Lishui, Nanjing, Nanning, Shanghai, Tianjin, Wuhan, Yantai, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 64
- Run by
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07844187 - 1/2. fázisCsak meghívásosXS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 102
- Run by
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT06936527 - 2. fázisTaking peopleTafolecimab Combined With Chemoimmunotherapy as Neoadjuvant Treatment for pMMR/MSS Locally Advanced Colon Cancer
- Where
- Chongqing
- Életkor
- 18 év to 80 év
- People
- 70
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07840677 - 2. fázisTaking peoplectDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 23
- Run by
- Fudan University
See details and how to joinNCT07841236